- Home
- FUND vs ABEO Comparison
FUND vs ABEO Comparison
Compare FUND & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FUND
- ABEO
- Stock Information
- Founded
- FUND 1988
- ABEO N/A
- Country
- FUND Canada
- ABEO United States
- Employees
- FUND N/A
- ABEO N/A
- Industry
- FUND Investment Managers
- ABEO Biotechnology: Pharmaceutical Preparations
- Sector
- FUND Finance
- ABEO Health Care
- Exchange
- FUND Nasdaq
- ABEO Nasdaq
- Market Cap
- FUND 228.2M
- ABEO 237.4M
- IPO Year
- FUND N/A
- ABEO 1980
- Fundamental
- Price
- FUND $7.38
- ABEO $4.45
- Analyst Decision
- FUND
- ABEO Strong Buy
- Analyst Count
- FUND 0
- ABEO 5
- Target Price
- FUND N/A
- ABEO $17.00
- AVG Volume (30 Days)
- FUND 32.5K
- ABEO 493.1K
- Earning Date
- FUND 01-01-0001
- ABEO 03-20-2025
- Dividend Yield
- FUND 6.64%
- ABEO N/A
- EPS Growth
- FUND N/A
- ABEO N/A
- EPS
- FUND 0.93
- ABEO N/A
- Revenue
- FUND N/A
- ABEO N/A
- Revenue This Year
- FUND N/A
- ABEO N/A
- Revenue Next Year
- FUND N/A
- ABEO $561.86
- P/E Ratio
- FUND $8.33
- ABEO N/A
- Revenue Growth
- FUND N/A
- ABEO N/A
- 52 Week Low
- FUND $6.75
- ABEO $3.05
- 52 Week High
- FUND $8.47
- ABEO $8.45
- Technical
- Relative Strength Index (RSI)
- FUND 47.79
- ABEO 26.67
- Support Level
- FUND $7.31
- ABEO $4.95
- Resistance Level
- FUND $7.52
- ABEO $5.14
- Average True Range (ATR)
- FUND 0.09
- ABEO 0.25
- MACD
- FUND 0.02
- ABEO -0.05
- Stochastic Oscillator
- FUND 61.84
- ABEO 2.50
About FUND Sprott Focus Trust Inc.
Sprott Focus Trust Inc is a diversified closed-end investment company. Its primary investment objective is long-term capital growth. To achieve its objective, The Fund may invest its assets in equity securities and in direct obligations of the U.S. Government or its agencies and in the non-convertible preferred stocks & debt securities of domestic and foreign companies. It invests in various sectors, of which Materials, Financials, Energy, Information technology sector account for the majority weightage.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.